Difference between revisions of "Team:Stanford-Brown/SB16 BioMembrane Nylon"
| Line 132: | Line 132: | ||
</div> <!--END container--> | </div> <!--END container--> | ||
| − | |||
| − | </div | + | <!--TEXT BEGINS HERE--> |
| + | |||
| + | <div class="container"> | ||
| + | <!--SECTION TITLE BEGIN--> | ||
| + | <div class="row rowT"> | ||
| + | <div class="col-sm-12 col-PT"> | ||
| + | <h1 class="sectionTitle-L firstTitle">Nylon-6 Biosynthesis</h1> | ||
| + | |||
| + | </div> | ||
| + | </div> <!--END rowT--> | ||
| + | <!--SECTION TITLE END--> | ||
| + | |||
| + | <!--TEXT BEGIN--> | ||
| + | |||
| + | <div class="row"> | ||
| + | <div class="col-sm-12 pagetext"><h2>Human Collagen</h2><p></p></div> | ||
| + | |||
| + | <div class="col-sm-12 pagetext-L"><div class="text">Nylon-6 is industrially produced through the chain-growth polymerization of caprolactam, the cyclical form of 6-aminocaproic acid (6-ACA). Our team investigated potential biosynthesis routes for this monomer, looking for pathways with common starting substrates to design a production system for 6-ACA that could be implemented on an extraterrestrial body. Past retrosynthetic analyses have uncovered two fermentative pathways for the production of 6-ACA, which both lacked required biocatalytic steps until 2015. [1][2] Last October, researcher <a href="https://www.linkedin.com/in/stefan-turk-69375711">Stefan Turk</a> published a <a href="http://pubs.acs.org/doi/abs/10.1021/acssynbio.5b00129?journalCode=asbcd6">study</a> detailing and potential candidates enzymes for these steps and characterizing their activity in vivo in <i>E. coli.</i> [3] With the novel nature of his work in mind, our team contacted Turk in request of a sample of his engineered strain eAKP-672 with the highest 6-ACA yield when grown in glucose containing medium. We hoped to adjust Turk's synthetic plasmid designs and/or make our own genomic edits to optimize the metabolic flux of his biosynthetic pathways. Turk replied in the affirmative, shipping us two separate cell samples containing plasmids pAKP-96 and pAKP-444, which held the six enzymes necessary to induce one of the two above mentioned pathways in <i>E. coli.</i> | ||
| + | </div></div><!--END col-sm-12--> | ||
| + | |||
| + | |||
| + | |||
| + | </div> <!--END row--> | ||
| + | </div> <!--END container--> | ||
</body> | </body> | ||
</html> | </html> | ||
Revision as of 21:08, 19 October 2016
Nylon-6 Biosynthesis
Human Collagen
Nylon-6 is industrially produced through the chain-growth polymerization of caprolactam, the cyclical form of 6-aminocaproic acid (6-ACA). Our team investigated potential biosynthesis routes for this monomer, looking for pathways with common starting substrates to design a production system for 6-ACA that could be implemented on an extraterrestrial body. Past retrosynthetic analyses have uncovered two fermentative pathways for the production of 6-ACA, which both lacked required biocatalytic steps until 2015. [1][2] Last October, researcher Stefan Turk published a study detailing and potential candidates enzymes for these steps and characterizing their activity in vivo in E. coli. [3] With the novel nature of his work in mind, our team contacted Turk in request of a sample of his engineered strain eAKP-672 with the highest 6-ACA yield when grown in glucose containing medium. We hoped to adjust Turk's synthetic plasmid designs and/or make our own genomic edits to optimize the metabolic flux of his biosynthetic pathways. Turk replied in the affirmative, shipping us two separate cell samples containing plasmids pAKP-96 and pAKP-444, which held the six enzymes necessary to induce one of the two above mentioned pathways in E. coli.
